Russell Investments Group Ltd. Has $80.27 Million Holdings in Colgate-Palmolive (NYSE:CL)

Russell Investments Group Ltd. increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,007,211 shares of the company’s stock after purchasing an additional 36,346 shares during the period. Russell Investments Group Ltd. owned approximately 0.12% of Colgate-Palmolive worth $80,268,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vest Financial LLC grew its stake in shares of Colgate-Palmolive by 25.1% during the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares during the period. Central Bank & Trust Co. grew its stake in Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after acquiring an additional 250 shares during the period. Dynamic Advisor Solutions LLC grew its stake in Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after acquiring an additional 910 shares during the period. Sarasin & Partners LLP grew its stake in Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after acquiring an additional 49,980 shares during the period. Finally, Cornerstone Wealth Management LLC grew its stake in Colgate-Palmolive by 2.5% in the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after acquiring an additional 172 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the sale, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the transaction, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock worth $19,505,099 over the last 90 days. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 1.9 %

CL traded up $1.72 on Friday, hitting $91.01. 7,541,541 shares of the company were exchanged, compared to its average volume of 3,968,951. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $92.25. The company has a market cap of $74.81 billion, a PE ratio of 28.80, a PEG ratio of 3.42 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock’s fifty day moving average is $87.66 and its 200-day moving average is $81.54.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 earnings per share. Equities research analysts predict that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a $0.50 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Barclays boosted their target price on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research note on Friday, April 12th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. UBS Group upped their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Finally, Evercore ISI upped their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.